FONAR Corp. (FONR)
14.32
-0.29
(-1.98%)
USD |
NASDAQ |
Dec 08, 16:00
14.35
+0.03
(+0.21%)
Pre-Market: 20:00
FONAR EPS Diluted (Quarterly): 0.3368 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -0.1646 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
| Exagen, Inc. | -0.3089 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.67M |
| Revenue (Quarterly) | 26.04M |
| Total Expenses (Quarterly) | 23.78M |
| Enterprise Value | 62.22M |
| Gross Profit Margin (Quarterly) | 40.11% |
| Profit Margin (Quarterly) | 10.25% |
| Earnings Yield | 7.72% |
| Operating Earnings Yield | 11.11% |
| Normalized Earnings Yield | 7.724 |